Medtronic Stock Analysis (NYSE:MDT)

Add to My Stocks
$83.09 $0.04 (0.05%) MDT stock closing price Apr 28, 2017 (Closing)
Watch Robo Advisor Video of MDT Stock Analysis
Medtronic
Updated on : Apr 28, 2017
previous close
MDT 83.1 (0%)
S&P 500 2384.2 (0%)
Closing Price On: Apr 28, 2017
stock rating
RATING: ★★★★★★★★★★ (0/5)
Industry :
Medical Products
Sector :
Medical
5 Quarter Revenue
Revenue Growth
2017-Q3
$billion
%
YOY GROWTH
Compared to the industry
Long Term Growth
5 Year CAGR:
12.4%
Operating Profit
Operating Margin:
17.2%
Sector Average:
0.6%
5 Quarter Net Profit
Net Margins
2017-Q3
%
LTM Margin
Compared to the industry
Debt/Equity Ratio
Debt:
32.15B
Debt/Equity Ratio:
 0.65
Compared to the industry
Cash Flow
Operating cash flow:
$2.09B
Net Income:
$821M
Dividend Yield
MDT dividend yield:
2.01%
PROS      CONS
Operating Margins
Net Margins
Cash Flow
ROIC
ROE
FCF Margin
Long Term Growth
High Debt Burden
Rating: ★★★★★★★★★★ (0/5)
Relative Valuation
MDT PS :
3.9
Industry PS :
4.7
Sector:   Medical.   *PE adjusted for one time items.
Other Metrics
Return on Invested Capital:
6.1%
Return on Equity:
7.8%
Free Cash Flow Margin:
24.2%
Double Tap To Exit Full Screen
0:00
/

Medtronic Analysis Video

638 5 2 1

View Medtronic stock analysis video. This is our MDT analyst opinion covering the buy and sell arguments for MDT stock.

Medtronic PLC Stock Rating (3.6/5)

Our Medtronic stock opinion is based on fundamentals of the company. This Medtronic stock analysis is based on latest Q3 earnings for 2017. The stock price analysis takes into account a company's valuation metrics.

Should you buy MDT stock?

  • The TTM operating margin was good at 17.2% for Medtronic.
  • Net margins stood at a healthy 13.5% (average) for Medtronic in the Trailing Twelve Months.
  • The company has an operating cash flow which is 2.5 times the net income. We see this as a positive signal.
  • The price to earnings multiple of 18.3 is attractive when compared with the industry average PE ratio of 22.5.
  • Medtronic has an attractive ROIC (Return on Invested Capital) of 6.1%
  • Medtronic has a good Return On Equity (ROE) of 7.8%.
  • Medtronic has a healthy FCF (Free Cash Flow) margin of 24.2%.

Should you sell MDT stock?

  • Revenue growth of 12.4% has been weak over the last 5 years.
  • Medtronic is debt laden and has a high debt/equity ratio of  0.65.

Comments on this video and Medtronic stock

arnulacroix22 on Medtronic stock analysis ($78.79)
bullish
Watch Medtronic plc (MDT) stock, which reached a new all-time high in intraday trading on Friday's market activity. Check this out http://finance.crwe-pr.com/2015/02/20/me...
reply